InvestorsHub on MSN
BioAffinity Technologies receives Japanese patent allowance for CyPath Lung AI diagnostic test
The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive ...
Hello! I'm Nao, and I attend Carol Davila University of Medicine and Pharmacy in Romania 🇷🇴The long summer vacation is over, and classes for my second year of medical school have finally ...
Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado Anschutz School of Medicine ...
Glioma brain tumors are diffuse, so surgeons usually cannot excise all of the cancer during surgery. Currently, surgeons ...
I have completed a master's degree in a science-related graduate school and work as a researcher at a manufacturer. At "Kenro," I investigate prospective universities not just by their names or ...
A new review warns that the molecular tests defining modern glioma diagnosis remain out of reach for most of the world, and ...
SINCE the first edition of this book appeared in 1901 it has become a well-known manual of laboratory methods. Its usefulness may be judged from the succession of editions of continually increasing ...
A GC-MS metabolomics study of 55 cervical cancer patients has identified serum biomarkers linked to disease stage, treatment ...
Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado Anschutz School of Medicine ...
Glioma brain tumors are diffuse, so surgeons usually cannot excise all of the cancer during surgery. Currently, surgeons ...
Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today ...
Pathology professor Patrick Hsu’s $250,000 prize will accelerate the development of new gene-editing tools and artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results